Suxiang Chen

1.8k total citations · 1 hit paper
30 papers, 1.4k citations indexed

About

Suxiang Chen is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Suxiang Chen has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 3 papers in Genetics and 3 papers in Biomedical Engineering. Recurrent topics in Suxiang Chen's work include RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (12 papers) and DNA and Nucleic Acid Chemistry (7 papers). Suxiang Chen is often cited by papers focused on RNA Interference and Gene Delivery (13 papers), Advanced biosensing and bioanalysis techniques (12 papers) and DNA and Nucleic Acid Chemistry (7 papers). Suxiang Chen collaborates with scholars based in Australia, China and United States. Suxiang Chen's co-authors include Rakesh N. Veedu, Tao Wang, Lanmei Chen, Leon M. Larcher, Nan Liu, Fengqiu Zhang, Dongbin Yang, Phuong H.L. Tran, Changying Chen and Weihong Zhang and has published in prestigious journals such as Chemical Communications, Scientific Reports and Molecules.

In The Last Decade

Suxiang Chen

28 papers receiving 1.4k citations

Hit Papers

Progress, opportunity, and perspective on exosome isolati... 2020 2026 2022 2024 2020 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Progress, opportunity, and perspective on exosome isolation - efforts for efficient exosome-based theranostics
    2020 783 citations Lanmei Chen, Suxiang Chen et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suxiang Chen Australia 16 1.2k 432 243 78 78 30 1.4k
Chuanjiang He China 12 995 0.8× 524 1.2× 341 1.4× 109 1.4× 70 0.9× 19 1.4k
Leon M. Larcher Australia 10 1.3k 1.1× 450 1.0× 322 1.3× 91 1.2× 59 0.8× 12 1.5k
Dijie Li China 19 931 0.8× 354 0.8× 236 1.0× 49 0.6× 68 0.9× 37 1.2k
Dhanu Gupta Sweden 18 1.2k 1.0× 499 1.2× 183 0.8× 133 1.7× 60 0.8× 32 1.4k
Venkatareddy Nadithe United States 8 1.1k 0.9× 536 1.2× 169 0.7× 109 1.4× 35 0.4× 9 1.3k
Samuele Raccosta Italy 17 1.4k 1.1× 921 2.1× 138 0.6× 103 1.3× 47 0.6× 30 1.6k
Amr Alaarg Netherlands 9 820 0.7× 439 1.0× 130 0.5× 175 2.2× 43 0.6× 12 1.1k
Zongkang Zhang Hong Kong 18 1.0k 0.8× 182 0.4× 254 1.0× 85 1.1× 69 0.9× 27 1.4k

Countries citing papers authored by Suxiang Chen

Since Specialization
Citations

This map shows the geographic impact of Suxiang Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suxiang Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suxiang Chen more than expected).

Fields of papers citing papers by Suxiang Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suxiang Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suxiang Chen. The network helps show where Suxiang Chen may publish in the future.

Co-authorship network of co-authors of Suxiang Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Suxiang Chen. A scholar is included among the top collaborators of Suxiang Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suxiang Chen. Suxiang Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Suxiang, et al.. (2025). A single stereogenic center matters: Development of stereodefined anti-tau PMO-gapmers. Molecular Therapy — Nucleic Acids. 36(2). 102519–102519.
2.
Chen, Suxiang, et al.. (2024). Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases. BioDrugs. 38(2). 177–203. 32 indexed citations
3.
Le, Bao T., Suxiang Chen, & Rakesh N. Veedu. (2024). Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications. Biomolecules. 14(7). 883–883. 1 indexed citations
4.
Li, Yalin, et al.. (2024). Inhibition of survivin by 2′-O-methyl phosphorothioate-modified steric-blocking antisense oligonucleotides. RSC Advances. 14(19). 13336–13341. 2 indexed citations
5.
Tan, Yuqin, Tong Zheng, Min Chen, et al.. (2023). Alternative polyadenylation reprogramming of MORC2 induced by NUDT21 loss promotes KIRC carcinogenesis. JCI Insight. 8(18). 11 indexed citations
6.
Zahra, Qurat ul ain, et al.. (2023). Nanoparticles-assisted aptamer biosensing for the detection of environmental pathogens. Environmental Research. 238(Pt 1). 117123–117123. 15 indexed citations
7.
Rabiee, Navid, et al.. (2023). Metallic nanostructure-based aptasensors for robust detection of proteins. Nanoscale Advances. 6(3). 747–776. 17 indexed citations
8.
Rabiee, Navid, Suxiang Chen, Sepideh Ahmadi, & Rakesh N. Veedu. (2023). Aptamer-engineered (nano)materials for theranostic applications. Theranostics. 13(15). 5183–5206. 21 indexed citations
9.
Tan, Yuqin, Tong Zheng, Rui Zhang, et al.. (2022). Alternative polyadenylation writer CSTF2 forms a positive loop with FGF2 to promote tubular epithelial-mesenchymal transition and renal fibrosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1868(12). 166541–166541. 7 indexed citations
10.
Wang, Xin, Suxiang Chen, Ruofei Du, et al.. (2022). Improving compliance with swallowing exercise to decrease radiotherapy-related dysphagia in patients with head and neck cancer. Asia-Pacific Journal of Oncology Nursing. 10(1). 100169–100169. 4 indexed citations
11.
Li, Yalin, Yuqin Tan, Rui Zhang, et al.. (2022). Antisense Oligonucleotide: A Potential Therapeutic Intervention for Chronic Kidney Disease. MDPI (MDPI AG). 2(1). 16–37. 5 indexed citations
12.
Wang, Tao, et al.. (2021). Development of nucleic acid aptamer-based lateral flow assays: A robust platform for cost-effective point-of-care diagnosis. Theranostics. 11(11). 5174–5196. 75 indexed citations
13.
Chen, Lanmei, Suxiang Chen, Jing‐Jing Zhang, et al.. (2021). Cyclometalated Ru(II)-isoquinoline complexes overcome cisplatin resistance of A549/DDP cells by downregulation of Nrf2 via Akt/GSK-3β/Fyn pathway. Bioorganic Chemistry. 119. 105516–105516. 11 indexed citations
14.
Chen, Jincan, Yuanyuan Deng, Jie Wang, et al.. (2021). Cyclometalated Ru(II) β-carboline complexes induce cell cycle arrest and apoptosis in human HeLa cervical cancer cells via suppressing ERK and Akt signaling. JBIC Journal of Biological Inorganic Chemistry. 26(7). 793–808. 11 indexed citations
15.
16.
Chen, Suxiang, et al.. (2019). Systematic evaluation of 2′-Fluoro modified chimeric antisense oligonucleotide-mediated exon skipping in vitro. Scientific Reports. 9(1). 6078–6078. 30 indexed citations
17.
Huang, He, et al.. (2018). Development of DNA aptamers targeting low-molecular-weight amyloid-β peptide aggregatesin vitro. Chemical Communications. 54(36). 4593–4596. 38 indexed citations
18.
Chen, Suxiang, et al.. (2018). Radiolabeling of Nucleic Acid Aptamers for Highly Sensitive Disease-Specific Molecular Imaging. Pharmaceuticals. 11(4). 106–106. 22 indexed citations
19.
Chen, Suxiang, et al.. (2017). Nucleic Acid-Based Theranostics for Tackling Alzheimer's Disease. Theranostics. 7(16). 3933–3947. 29 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chuanjiang He Breakdown of academic impact, for papers by Leon M. Larcher Breakdown of academic impact, for papers by Dijie Li Breakdown of academic impact, for papers by Dhanu Gupta Breakdown of academic impact, for papers by Venkatareddy Nadithe Breakdown of academic impact, for papers by Samuele Raccosta Breakdown of academic impact, for papers by Amr Alaarg Breakdown of academic impact, for papers by Zongkang Zhang
Rankless by CCL
2026